The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of androgen receptor signature and RB1, PTEN, TP53 gene expression with clinical outcome in metastatic hormone-sensitive prostate cancer treated with docetaxel and androgen deprivation therapy.
 
Laura Ferrer-Mileo
Honoraria - Bristol-Myers Squibb; Kyowa Kirin; Pfizer
Travel, Accommodations, Expenses - Kyowa Kirin; Pfizer
 
Natalia Jiménez
No Relationships to Disclose
 
Oscar Reig
No Relationships to Disclose
 
Miguel Ángel Climent
Honoraria - Astellas Oncology; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; EUNSA; Ipsen; Janssen; MSD; Pfizer; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Astellas Oncology; Ipsen; Janssen; MSD; Roche
 
Sara Cros
Honoraria - GlaxoSmithKline; Pfizer; Roche; Sanofi
Consulting or Advisory Role - GlaxoSmithKline; Pfizer; Sanofi
Research Funding - Janssen; Pfizer
Travel, Accommodations, Expenses - GlaxoSmithKline; Roche
 
Mariona Figols
Honoraria - Bristol-Myers Squibb; Merck; Pfizer; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Pfizer; Sanofi
Research Funding - Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Novartis; Sanofi
 
Albert Font
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Ipsen; Janssen; Roche; Sanofi
Research Funding - Astellas Oncology (Inst); AstraZeneca (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Janssen; Roche; Sanofi
 
Isabel Chirivella
Consulting or Advisory Role - Amgen; Astellas Oncology; Bayer; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Sanofi
Speakers' Bureau - Amgen; Astellas Oncology; Bayer; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Astellas Oncology; Janssen; Novartis; Pfizer; Sanofi
 
Alejo Rodriguez-Vida
Honoraria - Astellas Oncology; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; MSD; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Oncology; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen; MSD; Pfizer; Roche
Research Funding - MSD; Pfizer; Takeda
Travel, Accommodations, Expenses - Astellas Oncology; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ipsen; Janssen; Novartis; Pfizer; Roche
 
Montserrat Domenech
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Lilly; Sanofi
 
Enrique Gonzalez-Billalabeitia
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Pfizer; Roche; Sanofi
 
Mayra Orrillo
No Relationships to Disclose
 
Giancarlo Castellano
No Relationships to Disclose
 
Leonardo Rodriguez-Carunchio
No Relationships to Disclose
 
Sherley Diaz
No Relationships to Disclose
 
Aleix Prat
Employment - Novartis (I)
Stock and Other Ownership Interests - Reveal Genomics
Honoraria - Amgen; Daiichi Sankyo; Guardant Health; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; NanoString Technologies (Inst); Novartis; Oncolytics; Pfizer; Puma Biotechnology; Roche
Research Funding - Incyte (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - HER2DX filing; PCT/EP2016/080056: HER2 AS A PREDICTOR OF RESPONSE TO DUAL HER2 BLOCKADE IN THE ABSENCE OF CYTOTOXIC THERAPY; WO/2018/096191. Chemoendocrine score (CES) Based on PAM50 for breast cancer with positive hormone receptors with an intermediate risk of recurrence
Travel, Accommodations, Expenses - Daiichi Sankyo
Other Relationship - Oncolytics; Peptomyc
 
Mercedes Marín-Aguilera
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Begona Mellado
Speakers' Bureau - Astellas Oncology; Bristol-Myers Squibb; Ipsen; Janssen; Novartis; Pfizer; Roche; Sanofi
Research Funding - Bayer; Janssen; Roche
Travel, Accommodations, Expenses - Janssen; Pfizer